Sphingosine-1-phosphate and oligodendrocytes: From cell development to the treatment of multiple sclerosis

Prostaglandins and Other Lipid Mediators

Volumn 91, Issue 3-4, 2010, Pages 139-144

  Coelho, Rochelle P ^a   Saini, Harsimran S ^a   Sato Bigbee, Carmen ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FTY20; Myelination; Oligodendrocytes; Sphingosine 1 phosphate

Indexed keywords

FINGOLIMOD; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTROPHIN 3; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

BRAIN DEVELOPMENT; CELL MATURATION; CENTRAL NERVOUS SYSTEM; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME METABOLISM; MONOTHERAPY; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PROTEIN PHOSPHORYLATION; REMYELINIZATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINEAGE; HUMANS; LYSOPHOSPHOLIPIDS; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 77949487624     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2009.04.002     Document Type: Review

References (93)

1. Rasband M.N., and Trimmer J.S. Developmental clustering of ion channels at and near the node of Ranvier. Dev Biol 236 (2001) 5-16
2. Dupree J.L., Girault J.A., and Popko B. Axo-glial interactions regulate the localization of axonal paranodal proteins. J Cell Biol 147 (1999) 1145-1152
3. Maceyka M.W., Milstien S., and Spiegel S. Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling. J Lipid Res (2008 Nov 5) [Epub ahead of print]
4. Im D.S., Heise C.E., Ancellin N., et al. Characterization of a novel sphingosine 1-phosphate receptor Edg-8. J Biol Chem 275 (2000) 14281-14286
5. Jaillard C., Harrison S., Stankoff B., et al. Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. J Neurosci 25 (2005) 1459-1469
6. Saini H.S., Coelho R.P., Goparaju S.K., et al. Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors. J Neurochem 95 (2005) 1298-1310
7. Fatatis A., and Miller R.J. Platelet-derived growth factor (PDGF)-induced Ca2+ signaling in the CG4 oligodendroglial cell line and in transformed oligodendrocytes expressing the beta-PDGF receptor. J Biol Chem 272 (1997) 4351-4358
8. Soliven B., Ma L., Bae H., Attali B., Sobko A., and Iwase T. PDGF upregulates delayed rectifier via Src family kinases and sphingosine kinase in oligodendroglial progenitors. Am J Physiol Cell Physiol 284 (2003) C85-C93
9. Hannun Y.A., and Obeid L.M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9 (2008) 139-150
10. Hait N.C., Oskeritzian C.A., Paugh S.W., Milstien S., and Spiegel S. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 1758 (2006) 2016-2026
11. Spiegel S., and Milstien S. Functions of the multifaceted family of sphingosine kinases and some close relatives. J Biol Chem 282 (2007) 2125-2129
12. Wattenberg B.W., Pitson S.M., and Raben D.M. The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function. J Lipid Res 47 (2006) 1128-1139
13. Mandala S.M., Thornton R., Galve-Roperh I., et al. Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death. Proc Natl Acad Sci USA 97 (2000) 7859-7864
14. Le Stunff H., Galve-Roperh I., Peterson C., Milstien S., and Spiegel S. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis. J Cell Biol 158 (2002) 1039-1049
15. Van Veldhoven P.P., Gijsbers S., Mannaerts G.P., Vermeesch J.R., and Brys V. Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22(1). Biochim Biophys Acta 1487 (2000) 128-134
16. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 5 (2005) 560-570
17. Spiegel S., and Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4 (2003) 397-407
18. Chun J., Contos J.J., and Munroe D. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs). Cell Biochem Biophys 30 (1999) 213-242
19. Olivera A., and Spiegel S. Sphingosine kinase: a mediator of vital cellular functions. Prostagland Other Lipid Mediat 64 (2001) 123-134
20. Kohno M., Momoi M., Oo M.L., et al. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol Cell Biol 26 (2006) 7211-7223
21. Gillies L., Lee S.C., Long J.S., Ktistakis N., Pyne N.J., and Pyne S. The sphingosine 1-phosphate receptor 5 and sphingosine kinases 1 and 2 are localised in centrosomes: possible role in regulating cell division. Cell Signal 21 (2009) 675-684
22. LeVine S.M., and Goldman J.E. Spatial and temporal patterns of oligodendrocyte differentiation in rat cerebrum and cerebellum. J Comp Neurol 277 (1988) 441-455
23. Yu W.P., Collarini E.J., Pringle N.P., and Richardson W.D. Embryonic expression of myelin genes: evidence for a focal source of oligodendrocyte precursors in the ventricular zone of the neural tube. Neuron 12 (1994) 1353-1362
24. Hardy R.J. Dorsoventral patterning and oligodendroglial specification in the developing central nervous system. J Neurosci Res 50 (1997) 139-145
25. Armstrong R.C. Isolation and characterization of immature oligodendrocyte lineage cells. Methods 16 (1998) 282-292
26. Butt A.M., and Ransom B.R. Morphology of astrocytes and oligodendrocytes during development in the intact rat optic nerve. J Comp Neurol 338 (1993) 141-158
27. Pringle N.P., Mudhar H.S., Collarini E.J., and Richardson W.D. PDGF receptors in the rat CNS: during late neurogenesis. PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development 115 (1992) 535-551
28. Sommer I., and Schachner M. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol 83 (1981) 311-327
29. Campagnoni A.T. Molecular biology of myelin proteins from the central nervous system. J Neurochem 51 (1988) 1-14
30. Baumann N., and Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81 (2001) 871-927
31. Nishiyama A., Lin X.H., Giese N., Heldin C.H., and Stallcup W.B. Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain. J Neurosci Res 43 (1996) 299-314
32. Terai K., Soga T., Takahashi M., et al. Edg-8 receptors are preferentially expressed in oligodendrocyte lineage cells of the rat CNS. Neuroscience 116 (2003) 1053-1062
33. Yu N., Lariosa-Willingham K.D., Lin F.F., Webb M., and Rao T.S. Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes. Glia 45 (2004) 17-27
34. Novgorodov A.S., El-Alwani M., Bielawski J., Obeid L.M., and Gudz T.I. Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. Faseb J 21 (2007) 1503-1514
35. Calver A.R., Hall A.C., Yu W.P., et al. Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20 (1998) 869-882
36. Grinspan J., Wrabetz L., and Kamholz J. Oligodendrocyte maturation and myelin gene expression in PDGF-treated cultures from rat cerebral white matter. J Neurocytol 22 (1993) 322-333
37. McKinnon R.D., Matsui T., Dubois-Dalcq M., and Aaronson S.A. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5 (1990) 603-614
38. Armstrong R.C., Harvath L., and Dubois-Dalcq M.E. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J Neurosci Res 27 (1990) 400-407
39. Vana A.C., Flint N.C., Harwood N.E., Le T.Q., Fruttiger M., and Armstrong R.C. Platelet-derived growth factor promotes repair of chronically demyelinated white matter. J Neuropathol Exp Neurol 66 (2007) 975-988
40. Kumar S., Biancotti J.C., Yamaguchi M., and de Vellis J. Combination of growth factors enhances remyelination in a cuprizone-induced demyelination mouse model. Neurochem Res 32 (2007) 783-797
41. Fatatis A., and Miller R.J. Sphingosine and sphingosine 1-phosphate differentially modulate platelet-derived growth factor-BB-induced Ca2+ signaling in transformed oligodendrocytes. J Biol Chem 271 (1996) 295-301
42. Knutson P., Ghiani C.A., Zhou J.M., Gallo V., and McBain C.J. K+ channel expression and cell proliferation are regulated by intracellular sodium and membrane depolarization in oligodendrocyte progenitor cells. J Neurosci 17 (1997) 2669-2682
43. Cohen R.I., Marmur R., Norton W.T., Mehler M.F., and Kessler J.A. Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes. J Neurosci 16 (1996) 6433-6442
44. Kahn M.A., Kumar S., Liebl D., Chang R., Parada L.F., and De Vellis J. Mice lacking NT-3, and its receptor TrkC, exhibit profound deficiencies in CNS glial cells. Glia 26 (1999) 153-165
45. Kumar S., Kahn M.A., Dinh L., and de Vellis J. NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo. J Neurosci Res 54 (1998) 754-765
46. Barres B.A., Raff M.C., Gaese F., Bartke I., Dechant G., and Barde Y.A. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367 (1994) 371-375
47. Barres B.A., and Raff M.C. Control of oligodendrocyte number in the developing rat optic nerve. Neuron 12 (1994) 935-942
48. Kavanaugh B., Beesley J., Itoh T., Itoh A., Grinspan J., and Pleasure D. Neurotrophin-3 (NT-3) diminishes susceptibility of the oligodendroglial lineage to AMPA glutamate receptor-mediated excitotoxicity. J Neurosci Res 60 (2000) 725-732
49. Heinrich M., Gorath M., and Richter-Landsberg C. Neurotrophin-3 (NT-3) modulates early differentiation of oligodendrocytes in rat brain cortical cultures. Glia 28 (1999) 244-255
50. Rubio N., Rodriguez R., and Arevalo M.A. In vitro myelination by oligodendrocyte precursor cells transfected with the neurotrophin-3 gene. Glia 47 (2004) 78-87
51. Jean I., Lavialle C., Barthelaix-Pouplard A., and Fressinaud C. Neurotrophin-3 specifically increases mature oligodendrocyte population and enhances remyelination after chemical demyelination of adult rat CNS. Brain Res 972 (2003) 110-118
52. McTigue D.M., Horner P.J., Stokes B.T., and Gage F.H. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 18 (1998) 5354-5365
53. Johnson J.R., Chu A.K., and Sato-Bigbee C. Possible role of CREB in the stimulation of oligodendrocyte precursor cell proliferation by neurotrophin-3. J Neurochem 74 (2000) 1409-1417
54. Saini H.S., Gorse K.M., Boxer L.M., and Sato-Bigbee C. Neurotrophin-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte progenitor cells. J Neurochem 89 (2004) 951-961
55. Hida H., Nagano S., Takeda M., and Soliven B. Regulation of mitogen-activated protein kinases by sphingolipid products in oligodendrocytes. J Neurosci 19 (1999) 7458-7467
56. Pitson S.M., Xia P., Leclercq T.M., et al. Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. J Exp Med 201 (2005) 49-54
57. Johnson K.R., Becker K.P., Facchinetti M.M., Hannun Y.A., and Obeid L.M. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J Biol Chem 277 (2002) 35257-35262
58. Casaccia-Bonnefil P., Aibel L., and Chao M.V. Central glial and neuronal populations display differential sensitivity to ceramide-dependent cell death. J Neurosci Res 43 (1996) 382-389
59. Larocca J.N., Farooq M., and Norton W.T. Induction of oligodendrocyte apoptosis by C2-ceramide. Neurochem Res 22 (1997) 529-534
60. Craighead M., Pole J., and Waters C. Caspases mediate C2-ceramide-induced apoptosis of the human oligodendroglial cell line, MO3.13. Neurosci Lett 278 (2000) 125-128
61. Jatana M., Giri S., and Singh A.K. Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. Neurosci Lett 330 (2002) 183-187
62. Jana A., and Pahan K. Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis. J Neuroimmune Pharmacol 2 (2007) 184-193
63. Singh I., Pahan K., Khan M., and Singh A.K. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem 273 (1998) 20354-20362
64. Rausch M., Hiestand P., Foster C.A., Baumann D.R., Cannet C., and Rudin M. Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging 20 (2004) 16-24
65. Webb M., Tham C.S., Lin F.F., et al. Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice. J Neuroimmunol 153 (2004) 108-121
66. Fujino M., Funeshima N., Kitazawa Y., et al. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J Pharmacol Exp Ther 305 (2003) 70-77
67. Im D.S. Linking Chinese medicine and G-protein-coupled receptors. Trends Pharmacol Sci 24 (2003) 2-4
68. Zemann B., Kinzel B., Muller M., et al. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 107 (2006) 1454-1458
69. Chiba K., Hoshino Y., Suzuki C., et al. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplant Proc 28 (1996) 1056-1059
70. Maki T., Gottschalk R., and Monaco A.P. Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice. Transplantation 74 (2002) 1684-1686
71. Mizushima T., Ito T., Kishi D., et al. Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis. Inflamm Bowel Dis 10 (2004) 182-192
72. Kataoka H., Sugahara K., Shimano K., et al. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration. Cell Mol Immunol 2 (2005) 439-448
73. Brinkmann V., Davis M.D., Heise C.E., et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277 (2002) 21453-21457
74. Balatoni B., Storch M.K., Swoboda E.M., et al. FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis. Brain Res Bull 74 (2007) 307-316
75. O'Connor P., Comi G., Montalban X., et al. Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study. Neurology 72 (2009) 73-79
76. Brinkmann V., Cyster J.G., and Hla T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 4 (2004) 1019-1025
77. Mandala S., Hajdu R., Bergstrom J., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296 (2002) 346-349
78. Lan Y.Y., De Creus A., Colvin B.L., et al. The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo. Am J Transplant 5 (2005) 2649-2659
79. Muller H., Hofer S., Kaneider N., et al. The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur J Immunol 35 (2005) 533-545
80. Payne S.G., Oskeritzian C.A., Griffiths R., et al. The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. Blood 109 (2007) 1077-1085
81. Foster C.A., Mechtcheriakova D., Storch M.K., et al. FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol 19 (2009) 254-266
82. Brinkmann V., and Lynch K.R. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr Opin Immunol 14 (2002) 569-575
83. Coelho R.P., Payne S.G., Bittman R., Spiegel S., and Sato-Bigbee C. The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. J Pharmacol Exp Ther 323 (2007) 626-635
84. Jung C.G., Kim H.J., Miron V.E., et al. Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia 55 (2007) 1656-1667
85. Miron V.E., Jung C.G., Kim H.J., Kennedy T.E., Soliven B., and Antel J.P. FTY720 modulates human oligodendrocyte progenitor process extension and survival. Ann Neurol 63 (2008) 61-71
86. Miron V.E., Hall J.A., Kennedy T.E., Soliven B., and Antel J.P. Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod. Am J Pathol 173 (2008) 1143-1152
87. McQualter J.L., and Bernard C.C. Multiple sclerosis: a battle between destruction and repair. J Neurochem 100 (2007) 295-306
88. Zhao C., Fancy S.P., Magy L., Urwin J.E., and Franklin R.J. Stem cells, progenitors and myelin repair. J Anat 207 (2005) 251-258
89. Meno-Tetang G.M., Li H., Mis S., et al. Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses. Drug Metab Dispos 34 (2006) 1480-1487
90. Oyama Y., Chikahisa L., Kanemaru K., et al. Cytotoxic actions of FTY720, a novel immunosuppressant, on thymocytes and brain neurons dissociated from the rat. Jpn J Pharmacol 76 (1998) 377-385
91. Williams A., Piaton G., and Lubetzki C. Astrocytes-friends or foes in multiple sclerosis?. Glia 55 (2007) 1300-1312
92. Osinde M., Mullershausen F., and Dev K.K. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology 52 (2007) 1210-1218
93. Mullershausen F., Craveiro L.M., Shin Y., et al. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. J Neurochem 102 (2007) 1151-1161